2cureX AB (publ) Share Price Nasdaq Stockholm
Equities
SE0010468124
Biotechnology & Medical Research
Sales 2021 | 7.39M 694K 57.87M | Sales 2022 | 3.37M 316K 26.38M | Capitalization | 143M 13.47M 1.12B |
---|---|---|---|---|---|
Net income 2021 | -18M -1.69M -141M | Net income 2022 | -29M -2.72M -227M | EV / Sales 2021 | 29.9 x |
Net cash position 2021 | 72.94M 6.85M 571M | Net cash position 2022 | 44.89M 4.22M 352M | EV / Sales 2022 | 29.3 x |
P/E ratio 2021 |
-14.6
x | P/E ratio 2022 |
-4.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 34.45% |
Latest transcript on 2cureX AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01/21/01 | |
Grith Hagel
FOU | Founder | 65 | 01/06/01 |
Ole Thastrup
FOU | Founder | 71 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ole Thastrup
FOU | Founder | 71 | 01/06/01 |
Chairman | - | 14/11 |
1st Jan change | Capi. | |
---|---|---|
-27.90% | 9.96B | |
-4.81% | 3.03B | |
+31.37% | 3B | |
-14.73% | 2.18B | |
-14.39% | 1.76B | |
+70.99% | 1.42B | |
+23.17% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |